Biography

Dr. Gutierrez-Ramos serves as Chief Science Officer at the Danaher Corporation. Prior to Danaher, he served as the Head of Global Drug Discovery at AbbVie Inc. Previously, Dr. Gutierrez-Ramos was Group Senior Vice President Biotherapeutics R&D at Pfizer Inc. and Senior Vice President and CEDD Head of Immuno Inflammation at GlaxoSmithKline plc. He was the founding CEO and President at Repertoire Immune Medicine, where he built and led a team to decode the human immunome. Previously, Dr. Gutierrez-Ramos was President and CEO of Synlogic, Inc., where he led the company from early discovery to the clinical stage and to the public markets. As a biotech leader or in global positions, he oversaw multiple drug discovery teams, resulting in five marketed drugs. He previously served in a series of progressively more responsible research and development roles at Avidia (acquired by Amgen Inc.) and Millennium Pharmaceuticals, Inc. (acquired by Takeda Oncology).

Prior to working in the private sector, Dr. Gutierrez-Ramos was a tenure track professor at Harvard Medical School in the Department of Genetics. He was also a professor for the Spanish Scientific Research Council (CSIC) at the National Center of Biotechnology in Madrid, Spain. He was a scientist and member at the prestigious Basel Institute for Immunology in Basel, Switzerland and a Postdoctoral Fellow at the Max Plank Institute for Immunbiologie in Freiburg, Germany.

Dr. Gutierrez-Ramos earned a Ph.D. from the Immunology Department of the Center for Molecular Biology at the Universidad Autonoma de Madrid, Spain and a Bachelor of Science degree, summa cum laude, in Chemistry with a minor in Biochemistry from the Universidad Complutense de Madrid, Spain.